These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 15247597
1. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Geelen SP, Kimpen JL, Schoeman JF. Pediatr Infect Dis J; 2004 Jul; 23(7):608-13. PubMed ID: 15247597 [Abstract] [Full Text] [Related]
3. Role of vascular endothelial growth factor in tuberculous meningitis: A prospective study from a tertiary care center in North India. Kumar D, Singh D, Modi T, Sharma R, Awasthy AK, Shree R, Goyal MK, Narang D, Chand S, Vyas S, Sharma K, Sharma N, Gowda R, Goel A, Ranjan R, Modi M. Indian J Pharmacol; 2023 Jul; 55(4):216-222. PubMed ID: 37737073 [Abstract] [Full Text] [Related]
4. The association between blood-cerebrospinal fluid barrier dysfunction and the therapeutic effect in tuberculous meningitis patients. Tang J, An Y, Liao Y, Li Y, Li L, Wang L. Eur Neurol; 2014 Jul; 71(5-6):331-6. PubMed ID: 24776964 [Abstract] [Full Text] [Related]
5. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Pediatrics; 1997 Feb; 99(2):226-31. PubMed ID: 9024451 [Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van Diemen-Steenvoorde RA, van der Vlist GJ, Rupert SW, Schmutzhard E, Gunsilius E, Gastl G, Hoepelman AI, Kimpen JL, Geelen SP. J Infect Dis; 2001 Jan 01; 183(1):149-53. PubMed ID: 11106541 [Abstract] [Full Text] [Related]
9. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. Ann Trop Paediatr; 2001 Dec 01; 21(4):299-305. PubMed ID: 11732147 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis. Husain N, Awasthi S, Haris M, Gupta RK, Husain M. J Infect; 2008 Feb 01; 56(2):114-9. PubMed ID: 18158186 [Abstract] [Full Text] [Related]
11. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Schoeman J, Donald P, van Zyl L, Keet M, Wait J. Dev Med Child Neurol; 1991 May 01; 33(5):396-405. PubMed ID: 2065826 [Abstract] [Full Text] [Related]
12. Factors influencing the presentation and outcome of tuberculous meningitis in childhood. Faella FS, Pagliano P, Attanasio V, Rossi M, Rescigno C, Scarano F, Conte M, Fusco U. In Vivo; 2006 May 01; 20(1):187-91. PubMed ID: 16433051 [Abstract] [Full Text] [Related]
13. Adenylate kinase activity in the cerebrospinal fluid of children with tuberculous meningitis and its relationship to neurological outcome. Carlini SM, Beyers N, Schoeman JF, Nel ED, Truter EJ, Donald PR. Scand J Infect Dis; 1997 May 01; 29(3):275-80. PubMed ID: 9255889 [Abstract] [Full Text] [Related]